I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| regulatory T cell | 5 studies | 18% ± 2% | |
| conventional dendritic cell | 4 studies | 30% ± 16% | |
| non-classical monocyte | 4 studies | 28% ± 9% | |
| dendritic cell | 3 studies | 39% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| regulatory T cell | 5 studies | 18% ± 2% | |
| conventional dendritic cell | 4 studies | 30% ± 16% | |
| non-classical monocyte | 4 studies | 28% ± 9% | |
| dendritic cell | 3 studies | 39% ± 8% |
Insufficient scRNA-seq data for expression of SNX20 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 100% | 579.23 | 578 / 578 | 93% | 5.55 | 1077 / 1155 |
| breast | 81% | 97.69 | 372 / 459 | 92% | 5.30 | 1027 / 1118 |
| intestine | 84% | 272.48 | 811 / 966 | 83% | 4.80 | 440 / 527 |
| stomach | 75% | 95.11 | 270 / 359 | 87% | 4.72 | 249 / 286 |
| esophagus | 78% | 94.95 | 1134 / 1445 | 73% | 2.18 | 134 / 183 |
| bladder | 81% | 114.76 | 17 / 21 | 70% | 3.63 | 353 / 504 |
| uterus | 66% | 64.71 | 113 / 170 | 79% | 3.51 | 363 / 459 |
| thymus | 68% | 115.49 | 447 / 653 | 73% | 6.21 | 439 / 605 |
| kidney | 47% | 88.25 | 42 / 89 | 84% | 4.47 | 758 / 901 |
| prostate | 82% | 122.46 | 200 / 245 | 50% | 1.22 | 249 / 502 |
| skin | 50% | 49.31 | 913 / 1809 | 76% | 5.84 | 359 / 472 |
| pancreas | 20% | 22.21 | 67 / 328 | 87% | 4.45 | 154 / 178 |
| liver | 58% | 56.07 | 131 / 226 | 47% | 1.46 | 192 / 406 |
| adrenal gland | 86% | 103.69 | 221 / 258 | 19% | 0.37 | 44 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 48.65 | 29 / 29 |
| peripheral blood | 100% | 3817.10 | 929 / 929 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2311.37 | 241 / 241 | 0% | 0 | 0 / 0 |
| brain | 38% | 49.33 | 1015 / 2642 | 61% | 2.29 | 432 / 705 |
| ovary | 31% | 26.44 | 55 / 180 | 68% | 2.16 | 293 / 430 |
| adipose | 95% | 180.03 | 1149 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 8.72 | 42 / 45 |
| blood vessel | 69% | 104.74 | 923 / 1335 | 0% | 0 | 0 / 0 |
| heart | 34% | 30.84 | 290 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 19% | 0.59 | 15 / 80 |
| muscle | 2% | 1.29 | 14 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0015031 | Biological process | protein transport |
| GO_0031901 | Cellular component | early endosome membrane |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
| GO_1901981 | Molecular function | phosphatidylinositol phosphate binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0032266 | Molecular function | phosphatidylinositol-3-phosphate binding |
| Gene name | SNX20 |
| Protein name | Sorting nexin-20 (Selectin ligand-interactor cytoplasmic 1) (SLIC-1) |
| Synonyms | SLIC1 |
| Description | FUNCTION: May play a role in cellular vesicle trafficking. Has been proposed to function as a sorting protein that targets SELPLG into endosomes, but has no effect on SELPLG internalization from the cell surface, or on SELPLG-mediated cell-cell adhesion. . |
| Accessions | ENST00000568993.5 [Q7Z614-3] ENST00000423026.6 [Q7Z614-4] ENST00000300590.7 [Q7Z614-3] ENST00000330943.9 [Q7Z614-1] Q7Z614 |
